Consumer interpretation of ramipril and clopidogrel medication risk information – Implications for risk communication strategies

Tong, V, Raynor, DK, Blalock, SJ et al. (1 more author) (2015) Consumer interpretation of ramipril and clopidogrel medication risk information – Implications for risk communication strategies. Patient Preference and Adherence, 9. 983 - 988. ISSN 1177-889X

Abstract

Metadata

Authors/Creators:
  • Tong, V
  • Raynor, DK
  • Blalock, SJ
  • Aslani, P
Copyright, Publisher and Additional Information: © 2015 Tong et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Keywords: adverse effects; risk assessmen; drug labeling; consumer participation; comprehension
Dates:
  • Accepted: 20 May 2015
  • Published: 9 July 2015
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Healthcare (Leeds) > Pharmacy (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 18 Aug 2015 10:00
Last Modified: 26 Feb 2019 09:28
Published Version: http://dx.doi.org/10.2147/PPA.S86414
Status: Published
Publisher: Dove Medical Press
Identification Number: https://doi.org/10.2147/PPA.S86414

Export

Statistics